Integra LifeSciences Holdings CorporationIART has finally come up with the news of completing Codman Neurosurgery business acquisition from Johnson & Johnson JNJ. This development was expected at the ...
Add Yahoo as a preferred source to see more of our stories on Google. By Divya Grover (Reuters) - Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman ...
Integra LifeSciences Holdings CorporationIART recently signed a definitive agreement to sell the company's certain neurosurgery assets to healthcare products and services provider Natus Medical ...
Integra Lifesciences Holding Corp. has made a bid to acquire Johnson & Johnson Corp.'s (J&J) Codman Neurosurgery business for $1.05 billion in cash. The neurosurgery business is part of New Brunswick, ...
Medical device maker Integra LifeSciences Holdings Corp said on Wednesday it has offered to buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash. Integra, which makes ...
Integra Lifesciences Holdings Corporation IART recently presented promising clinical and financial results for the Codman Bactiseal External Ventricular Drain (EVD) catheter set in the treatment of ...
WASHINGTON (Reuters) - Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said ...
Integra LifeSciences Holdings Corp.IART-3.25%decrease; red down pointing triangle said Wednesday that it made an offer to buy Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion ...
Acclarent will become part of Integra’s Codman Specialty Surgical unit—which it also picked up from J&J, through a $1 billion deal in late 2017. (Getty Images) Johnson & Johnson MedTech has agreed to ...
(Reuters) - Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the ...
Integra LifeSciences Holdings Corp. said Wednesday that it was paying $1.05 billion in cash to buy Johnson & Johnson's Codman Neurosurgery business. Codman's devices are focused on hydrocephalus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results